C M Hogaboam Selected Research

Nitric Oxide (Nitrogen Monoxide)

6/2000

Acute inhibition of nitric oxide exacerbates airway hyperresponsiveness, eosinophilia and C-C chemokine generation in a murine model of fungal asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C M Hogaboam Research Topics

Disease

10	Inflammation (Inflammations) 08/2008 - 03/2000
7	Respiratory Hypersensitivity 08/2008 - 01/2000
7	Asthma (Bronchial Asthma) 03/2006 - 01/2000
6	Sepsis (Septicemia) 03/2001 - 03/2000
5	Peritonitis 03/2001 - 03/2000
4	Colitis 07/2001 - 03/2000
3	Idiopathic Interstitial Pneumonias 11/2008 - 05/2004
3	Idiopathic Pulmonary Fibrosis 11/2008 - 05/2004
3	Airway Remodeling 05/2005 - 02/2001
2	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2008 - 05/2004
2	Communicable Diseases (Infectious Diseases) 11/2008 - 01/2000
2	Lung Diseases (Lung Disease) 05/2005 - 05/2001
2	Eosinophilia 05/2005 - 06/2000
2	Fibrosis (Cirrhosis) 11/2001 - 02/2000
2	Infections 07/2001 - 07/2001
2	Hyperplasia 04/2001 - 02/2000
2	Pathologic Processes 04/2000 - 01/2000
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2000 - 03/2000
1	Pulmonary Sarcoidosis 04/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	Lung Injury 01/2018
1	Allergic Bronchopulmonary Aspergillosis 03/2006
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 05/2005
1	Respiratory Syncytial Virus Infections 07/2001
1	Cestode Infections (Tapeworm Infection) 07/2001
1	Liver Diseases (Liver Disease) 10/2000
1	Hypersensitivity (Allergy) 06/2000
1	Neoplasms (Cancer) 04/2000
1	Crohn Disease (Crohn's Disease) 03/2000
1	Ulcerative Colitis 03/2000

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 04/2018 - 03/2000
9	ChemokinesIBA 05/2005 - 01/2000
5	CC ChemokinesIBA 06/2007 - 05/2000
5	Interleukin-13IBA 05/2004 - 03/2000
3	CollagenIBA 11/2001 - 01/2000
2	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2008 - 05/2005
2	LigandsIBA 11/2008 - 06/2007
2	Chemokine CCL22IBA 05/2005 - 05/2000
2	Immunoglobulin E (IgE)IBA 05/2005 - 08/2000
2	Interleukin-4 (Interleukin 4)IBA 05/2004 - 04/2001
2	Therapeutic UsesIBA 04/2001 - 03/2000
2	Proteins (Proteins, Gene)FDA Link 03/2001 - 01/2000
2	Interleukin-10 (Interleukin 10)IBA 03/2001 - 03/2000
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 02/2001 - 01/2001
1	Biomarkers (Surrogate Marker)IBA 04/2018
1	Interferon Type IIBA 04/2018
1	Toll-Like Receptor 3IBA 04/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	Antifungal AgentsIBA 03/2006
1	CCR7 ReceptorsIBA 01/2006
1	Immunoglobulin G (IgG)IBA 05/2005
1	AntigensIBA 05/2005
1	Chemokine CCL17IBA 05/2005
1	Pattern Recognition ReceptorsIBA 05/2005
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 05/2004
1	Interferon-gamma (Interferon, gamma)IBA 05/2004
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 05/2004
1	Interleukin-18 (Interleukin 18)IBA 11/2001
1	Chemokine ReceptorsIBA 11/2001
1	Chemokine CCL3IBA 11/2001
1	AllergensIBA 07/2001
1	Dextran SulfateIBA 07/2001
1	Drinking WaterIBA 07/2001
1	Sulfonic AcidsIBA 01/2001
1	Met- RANTESIBA 01/2001
1	Chemotactic FactorsIBA 01/2001
1	Messenger RNA (mRNA)IBA 01/2001
1	Chemokine CCL5IBA 01/2001
1	Stem Cell FactorIBA 10/2000
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2000
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 06/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2000
1	Monocyte Chemoattractant ProteinsIBA 04/2000
1	Endothelin Receptor AntagonistsIBA 03/2000
1	Endothelins (Endothelin)IBA 03/2000
1	Peroxidase (Myeloperoxidase)IBA 03/2000
1	Leukotriene B4IBA 03/2000
1	Ro 48-5695IBA 03/2000
1	2,4-dinitrofluorobenzene sulfonic acidIBA 03/2000
1	Endothelin-1 (Endothelin 1)IBA 03/2000
1	Methacholine Chloride (Methacholine)FDA Link 02/2000
1	Hydroxyproline (4 Hydroxyproline)IBA 02/2000
1	Neutralizing AntibodiesIBA 01/2000

Therapy/Procedure

5	Therapeutics 03/2006 - 05/2000
5	Ligation 11/2000 - 03/2000
5	Punctures 11/2000 - 03/2000
1	Rectal Administration 03/2000